Ether

Ether

SCHEMBL21111047

C/C=C\c1ccccc1OS(=O)(=O)O.CCOCC.N

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NFE2L2 Q16236 3/20 0.37
LMNA P02545 6/20 0.36
MAPT P10636 5/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ATM Q13315 1/20 0.36
TFEB P19484 1/20 0.36
BCHE P06276 2/20 0.35
ACHE P22303 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPK1 P28482 2/20 0.35
NPSR1 Q6W5P4 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
S1PR4 O95977 1/20 0.34
ITGA4 P13612 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL21110865 0.99 MEN1 (0.40) MEN1KMT2ANFE2L2LMNAMAPT
Ether SCHEMBL563787 0.84 NFE2L2 (0.50) MEN1KMT2ANFE2L2LMNAMAPT
Sulfuric Acid SCHEMBL3667450 0.77 HTT (0.44) MEN1KMT2ANFE2L2LMNAMAPT
SCHEMBL8029770 0.76 ALDH1A1 (0.43) MEN1KMT2ANFE2L2LMNAMAPT
SCHEMBL8029771 0.76 ALDH1A1 (0.43) MEN1KMT2ANFE2L2LMNAMAPT
Ether SCHEMBL1170797 0.76 NFE2L2 (0.43) NFE2L2LMNANPC1FABP1
Ether SCHEMBL21144482 0.75 SRC (0.55) MEN1KMT2ANFE2L2LMNAMAPT
Sulfuric Acid SCHEMBL21110870 0.75 HTT (0.45) MEN1KMT2ANFE2L2LMNAMAPT
Ether SCHEMBL21144490 0.74 KMT2A (0.38) MEN1KMT2ANFE2L2LMNAMAPT
Ether SCHEMBL1074739 0.73 ALDH1A1 (0.41) MEN1KMT2ALMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3955059-B1 METHOD FOR MANUFACTURING A FLEXOGRAPHIC PRINTING PLATE FUJIFILM CORP (JP) 2025-12-03 EP disclosed
US-12044971-B2 Aqueous developer for flexographic printing plate and manufacturing method of flexographic printing plate FUJIFILM CORPORATION (JP) 2024-07-23 US disclosed
US-11578028-B2 Surfactant composition DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 2023-02-14 US disclosed
EP-3955059-A1 WATER-BASED PHOTOGRAPHIC DEVELOPER FOR FLEXOGRAPHIC PRINTING PLATES, AND METHOD FOR MANUFACTURING FLEXOGRAPHIC PRINTING PLATE FUJIFILM Corporation (JP) 2022-02-16 EP disclosed
US-20220026808-A1 AQUEOUS DEVELOPER FOR FLEXOGRAPHIC PRINTING PLATE AND MANUFACTURING METHOD OF FLEXOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2022-01-27 US disclosed
US-10940453-B2 Surfactant composition DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 2021-03-09 US disclosed
EP-3508532-B1 SURFACTANT COMPOSITION DAI ICHI KOGYO SEIYAKU CO LTD (JP) 2020-12-23 EP disclosed
US-20200331830-A1 SURFACTANT COMPOSITION DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 2020-10-22 US disclosed
WO-2020189714-A1 RESIN COMPOSITION FOR AQUEOUS COATING MATERIALS, AND COATING FILM ハリマ化成株式会社 2020-09-24 WO disclosed
US-20190217265-A1 SURFACTANT COMPOSITION DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 2019-07-18 US disclosed
EP-3508532-A1 SURFACTANT COMPOSITION Dai-Ichi Kogyo Seiyaku Co., Ltd. (JP) 2019-07-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578028-B2 Surfactant composition CHRM1, DEGS1, ASH2L MEN1 2495/4885KMT2A 866/4885NFE2L2 4164/4885
US-20200331830-A1 SURFACTANT COMPOSITION CHRM1, DEGS1, ASH2L MEN1 2495/4885KMT2A 866/4885NFE2L2 4164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.